{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:08:57Z","timestamp":1792426137818,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer is an important cause of human death. We aimed to analyze the cancer burden in adolescents and young adults aged 10\u201324 years at global, regional, and national levels from 1990 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed global burden of disease (GBD) data from 1990 to 2021 to assess the cancer-related incidence, prevalence, death, disability-adjusted life-years (DALYs), and the corresponding age-standardized rates (ASRs) in adolescents and young adults aged 10\u201324 years by region, country, sociodemographic index(SDI), etiology and gender stratification. In addition, we evaluated health inequities caused by cancer burden from 1990 to 2021 and used bayesian age-period-cohort (BAPC) model to assess trend of the total cancer burden in adolescents and young adults aged 10\u201324 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, there were 235, 249.05(95%UI, 21, 7211.16 to 251, 1070.1) new cancer cases in adolescents and young adults aged 10\u201324 years and 94856.02 (95%UI: 85970.2 to 102769.63) deaths worldwide. In addition, there were 13499, 913.04 (95%UI, 1252506.95 to 1442998.32) prevalent cases and 6, 918, 657.72 (95%UI: 6, 254, 353.93 to 7, 480202.6) DALYs. Over the past 30 years, the age-standardized incidence rate (ASIR) and the age-standardized prevalence rate (ASPR) of total cancer in adolescents and young adults aged 10\u201324 years have increased globally, with the most significant increases in regions with high SDI, such as North America and parts of Europe and Asia. The age-standardized death rate(ASDR) and age-standardized DALY rate of total cancer have decreased significantly globally in adolescents and young adults aged 10\u201324 years. The ASDR and age-standardized DALY rate of total cancer in adolescents and young adults aged 10\u201324 years were highest in countries with lower SDI, particularly in South America and Africa. Among all regions, Tokelau, Niue, and Afghanistan had the highest ASDR in 2021. Among all cancers, leukemia, brain cancers and malignant neoplasm of bone &amp;amp; articular cartilage were the most common causes of cancer death in adolescents and young adults aged 10\u201324 years in 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Globally, the total cancer burden of adolescents and young adults aged 10\u201324 years have increased significantly over the past 30 years. Differences in adolescent and young adult cancer burden were evident across regions with different SDI levels. Developing effective strategies to reduce the total cancer burden of adolescents and young adults was critical to promoting global equity and population health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1663523","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:21:27Z","timestamp":1762147287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Global burden of cancer in adolescents and young adults aged 10\u201324 years: a trend analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Junjun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32427-9","article-title":"Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016","volume":"393","author":"Azzopardi","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01546-4","article-title":"Global, regional, and national mortality among young people aged 10\u201324 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(22)00073-6","article-title":"Burden of non-communicable diseases among adolescents aged 10\u201324 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019","volume":"6","author":"Armocida","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(23)00148-7","article-title":"Burden of non-communicable diseases among adolescents and young adults aged 10\u201324 years in the South-East Asia and Western Pacific regions, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Wang","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"101331","DOI":"10.1016\/j.xcrm.2023.101331","article-title":"Burden of noncommunicable diseases among children and adolescents aged 10\u201324 years in China, 1990-2019: A population-based study","volume":"4","author":"Zhang","year":"2023","journal-title":"Cell Rep Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001268","article-title":"The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional, and case\u2013control studies in surgery","volume":"110","author":"Rashid","year":"2024","journal-title":"Int J Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.eclinm.2020.100712","article-title":"Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017","volume":"32","author":"Zeng","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.994619","article-title":"Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29034","DOI":"10.3402\/gha.v8.29034","article-title":"Promoting health equity: WHO health inequality monitoring at global and national levels","volume":"8","author":"Hosseinpoor","year":"2015","journal-title":"Glob Health Action"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e58593","DOI":"10.1371\/journal.pone.0058593","article-title":"Comparison and relative utility of inequality measurements: as applied to Scotland\u2019s child dental health","volume":"8","author":"Blair","year":"2013","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/jcm12051828","article-title":"The global burden of glaucoma: findings from the global burden of disease 2019 study and predictions by bayesian age-period-cohort analysis","volume":"12","author":"Lin","year":"2023","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e069679","DOI":"10.1136\/bmj-2021-069679","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"Safiri","year":"2022","journal-title":"Bmj"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-021-01093-3","article-title":"The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990-2019: a population-based study","volume":"14","author":"Wen","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01367","article-title":"Survival trends among adolescents and young adults diagnosed with cancer in the United States: comparisons with children and older adults","volume":"42","author":"Keegan","year":"2024","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"113558","DOI":"10.1016\/j.ejca.2024.113558","article-title":"Survival of European adolescents and young adults diagnosed with cancer in 2010-2014","volume":"202","author":"Trama","year":"2024","journal-title":"Eur J Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-2045(21)00581-7","article-title":"The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"23","year":"2022","journal-title":"Lancet Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3928\/19382359-20211209-03","article-title":"Adolescents and young adults with cancer: survivorship and special considerations","volume":"51","author":"Joffe","year":"2022","journal-title":"Pediatr Ann"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.08.004","article-title":"Cancer-related fatigue in adolescents and young adults: A systematic review of the literature","volume":"118","author":"Nowe","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01504","article-title":"Health care transitions among adolescents and young adults with cancer","volume":"42","author":"Ehrhardt","year":"2024","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e27660","DOI":"10.1002\/pbc.27660","article-title":"Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults","volume":"66","author":"Salsman","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01465","article-title":"Psychological outcomes in adolescent and young adult cancer survivors","volume":"42","author":"McGrady","year":"2024","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.esmoop.2021.100096","article-title":"Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)","volume":"6","author":"Ferrari","year":"2021","journal-title":"ESMO Open"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2023.0013","article-title":"The delivery of palliative and end-of-life care to adolescents and young adults living with cancer: A scoping review","volume":"12","author":"Drake","year":"2023","journal-title":"J Adolesc Young Adult Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003140","article-title":"Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022","volume":"137","author":"Cao","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvad202","article-title":"Epidemiology of cancer","volume":"70","author":"Schwartz","year":"2024","journal-title":"Clin Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","article-title":"Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study","volume":"25","author":"De Angelis","year":"2024","journal-title":"Lancet Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70482-5","article-title":"Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer","volume":"14","author":"Morhason-Bello","year":"2013","journal-title":"Lancet Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70472-2","article-title":"Treatment of cancer in sub-Saharan Africa","volume":"14","author":"Kingham","year":"2013","journal-title":"Lancet Oncol"},{"key":"B33","first-page":"5","article-title":"Cancer in Africa: opportunities for collaborative research and training","author":"Adebamowo","year":"2009","journal-title":"Afr J Med Med Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2430975","DOI":"10.1001\/jamanetworkopen.2024.30975","article-title":"Racial disparities in cancer stage at diagnosis and survival for adolescents and young adults","volume":"7","author":"Taparra","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.7027","article-title":"Evaluation of socioeconomic and racial\/ethnic disparities in all-cause mortality in adolescents and young adults with cancer","volume":"22","author":"Henderson","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/10428194.2019.1658103","article-title":"The treatment of adolescents and young adults with acute lymphoblastic leukemia","volume":"61","author":"Advani","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jayao.2021.0033","article-title":"Acute lymphoblastic leukemia in adolescents and young adults: A polish perspective","volume":"11","author":"Derwich","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30468-X","article-title":"Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e18222","DOI":"10.1016\/j.heliyon.2023.e18222","article-title":"International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of disease","volume":"9","author":"Ilic","year":"2023","journal-title":"Heliyon"},{"key":"B42","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/foc.2006.20.4.E1","article-title":"Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001","volume":"20","author":"Deorah","year":"2006","journal-title":"Neurosurg Focus"},{"key":"B43","doi-asserted-by":"publisher","first-page":"117212","DOI":"10.1016\/j.bone.2024.117212","article-title":"Global, regional, and national burden and trends analysis of Malignant neoplasm of bone and articular cartilage from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"188","author":"Lai","year":"2024","journal-title":"Bone"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1252","article-title":"Epidemiology of gastric cancer: global trends, risk factors and premalignant conditions","volume":"13","author":"Grantham","year":"2023","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"B45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40364-024-00631-8","article-title":"Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021","volume":"12","author":"Sha","year":"2024","journal-title":"biomark Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00165-X","article-title":"The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends","volume":"9","author":"Huang","year":"2022","journal-title":"Lancet Haematol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1663523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:21:27Z","timestamp":1762147287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1663523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":48,"alternative-id":["10.3389\/fonc.2025.1663523"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1663523","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"article-number":"1663523"}}